Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
InnoCan Pharma (DE:IP4)
FRANKFURT:IP4
InnoCan Pharma (IP4) Stock Price & Analysis
1 Followers
IP4 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.13 - €0.35
Previous Close€0.21
Volume146.80K
Average Volume (3M)57.06K
Market Cap
€55.96M
Enterprise Value€52.67M
Total Cash (Recent Filing)$3.88M
Total Debt (Recent Filing)$33.00K
Price to Earnings (P/E)―
Beta0.74
Next Earnings
May 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding268,001,895
10 Day Avg. Volume76,565
30 Day Avg. Volume57,063
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)14.96
Price to Sales (P/S)3.86
Price to Cash Flow (P/CF)-11.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.86
Enterprise Value/Gross Profit4.40
Enterprise Value/Ebitda-13.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InnoCan Pharma News
PremiumCompany Announcements
InnoCan Pharma Advances Non-Opioid Pain Treatment
PremiumCompany Announcements
Innocan Pharma’s CBD Therapy Aids Injured Donkey
PremiumCompany Announcements
Innocan Pharma Seeks FDA Nod for Pain Therapy
PremiumCompany Announcements
Innocan Pharma’s Revenues Soar in 2023
PremiumCompany Announcements
Innocan Pharma Advances Towards FDA Approval
PremiumCompany Announcements
Innocan Pharma Secures C$2M in Private PlacementPremiumCompany Announcements
Innocan Pharma Advances Neurological Therapies and FundingPremiumCompany Announcements
Innocan Pharma’s LPT-CBD Shows Lasting Effects in StudyIP4 FAQ
What was InnoCan Pharma’s price range in the past 12 months?
InnoCan Pharma lowest stock price was €0.13 and its highest was €0.35 in the past 12 months.
What is InnoCan Pharma’s market cap?
Currently, no data Available
When is InnoCan Pharma’s upcoming earnings report date?
InnoCan Pharma’s upcoming earnings report date is May 28, 2024 which is in 4 days.
How were InnoCan Pharma’s earnings last quarter?
InnoCan Pharma released its earnings results on Apr 01, 2024. The company reported -€0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.003.
Is InnoCan Pharma overvalued?
According to Wall Street analysts InnoCan Pharma’s price is currently Overvalued.
Does InnoCan Pharma pay dividends?
InnoCan Pharma does not currently pay dividends.
What is InnoCan Pharma’s EPS estimate?
InnoCan Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InnoCan Pharma have?
Currently, no data Available
What happened to InnoCan Pharma’s price movement after its last earnings report?
InnoCan Pharma reported an EPS of -€0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.313%.
Which hedge fund is a major shareholder of InnoCan Pharma?
Currently, no hedge funds are holding shares in DE:IP4
---
InnoCan Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
24.17%
12-Months-Change
Fundamentals
Return on Equity
-89.55%
Trailing 12-Months
Asset Growth
-0.52%
Trailing 12-Months
Company Description
InnoCan Pharma
InnoCan Pharma Corp is a Canada based company engaged in the research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products. Its brands include Shir and Relief & Go.
---
Technical Analysis
---